A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation

By
Chenlu Hou
Yifan Zhang
Xiangqi Cao
Yonglan Tang
Ting Gao
Baoli Tang
Ying Zhu
Zhe Ruan
Ting Chang
June 3, 2026
0 min

Frontiers In Immunology

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

#1

Tangdu Hospital of Air Force Medical University

Xi'an, Shaanxi
Key Differentiators
- Neurology
#2

Cleveland Clinic

Cleveland, Ohio
Key Differentiators
- Neurology
#3

Charité—University Hospital Berlin

Berlin, Berlin
Key Differentiators
- Neurology
#4

Mayo Clinic

Rochester, Minnesota
Key Differentiators
- Neurology

Original Source(s)

Frontiers In Immunology

A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation

by Chenlu Hou, Yifan Zhang, Xiangqi Cao, Yonglan Tang, Ting Gao, Baoli Tang, Ying Zhu, Zhe Ruan, Ting Chang
June 3, 2026

Related Content

Frontiers In Neurology

Differential associations of novel metaflammation indices with incident stroke across traditional Chinese medicine constitutions: a retrospective community-based cohort study of older adults

by Yang Li, Jun Ni, You Li, Suyan Zhao, Yun Chen
June 3, 2026

Conexiant

Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease

In a multicenter registry study, genetic diagnoses were associated with substantially lower cognitive, language, and motor scores; while birth weight, surgical timing, hospitalization burden, and caregiver education were also associated with outcomes.